(Total Views: 1164)
Posted On: 11/14/2020 10:34:01 PM
Post# of 145249
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Leronlimab Treatment Inhibits CCR5 in Critically Ill COVID-19 Patients--Decreasing Inflammatory Cytokines, Increasing CD8 T-Cells, and Decreasing SARS-CoV-2 RNA in Plasma by Day 14
http://www.bioquicknews.com/node/5726?fbclid=...adhlXb6JYs
http://www.bioquicknews.com/node/5726?fbclid=...adhlXb6JYs
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)